Orchid Pharma receives US FDA approval for Olanzapine Tabs ANDA
| April 25, 2012
The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma)
today announced that it has received approval
from the US FDA
for its ANDA (Abbreviated New Drug Application) for Olanzapine Tablets
in the 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg strengths.
are the generic equivalent of Eli Lilly’s Zyprexa
® tablets. For the twelve months ending December 31, 2011 the total sales for this product in the US were approximately US$ 3.3 billion.
(Source: IMS Health, MAT 2011).